A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Oct 2018
At a glance
- Drugs Triheptanoin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms PALS
- 15 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated
- 09 Aug 2018 Status changed from not yet recruiting to recruiting.